ClassID:

95363

C07D471/08 - page 4 - CPC Classification

Classification description:

Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups  -  in which the condensed system contains two hetero rings Bridged systems

Recent Application in this class:
#901
20160096803
2016-04-07

Crystal of pyrrole derivative and method for producing the same

#902
20160081982
2016-03-24

Methods for treating pulmonary emphysema using substituted 2-Aza-bicyclo[2.2.1]heptane-3-carboxylic acid (benzyl-cyano-methyl)-amides inhibitors of cathepsin C

#903
20160075704
2016-03-17

Substituted spirocycles

#904
20160075696
2016-03-17

Substituted 2-azabicycles and their use as orexin receptor modulators

#905
20160068556
2016-03-10

Targeted nitroxide agents

#906
20160068524
2016-03-10

Inhibitors of leukotriene A4 hydrolase

#907
20160052940
2016-02-25

Biheteroaryl compounds and uses thereof

#908
20160052939
2016-02-25

Substituted 2-azabicycles and their use as orexin receptor modulators

#909
20160046616
2016-02-18

NRF2 SMALL MOLECULE INHIBITORS FOR CANCER THERAPY

#910
20160046606
2016-02-18

CXCR4 Receptor Antagonists

#911
20160039836
2016-02-11

P2X7 modulators

#912
20160039833
2016-02-11

Nicotinic acetylcholine receptor sub-type selective amides of diazabicycloalkanes

#913
20160039819
2016-02-11

Muscarinic agonists

#914
20160039761
2016-02-11

Heteroaryl compounds useful as inhibitors of E1 activating enzymes

#915
20160038487
2016-02-11

GLP-1 receptor modulators

#916
20160031893
2016-02-04

ANTIMICROBIAL COMPOUNDS AND METHODS OF MAKING AND USING THE SAME

#917
20160031861
2016-02-04

Substituted oxetanes and their use as inhibitors of cathepsin C

#918
20160024090
2016-01-28

β-lactamase inhibitor and process for preparing the same

#919
20160016955
2016-01-21

Process for sodium salt of (2S, 5R)-2-carboxamido-7-oxo-6-sulfooxy -1,6-diaza-bicyclo[3.2.1]octane

#920
20160016908
2016-01-21

2,3-disubstituted 1-acyl-4-amino-1,2,3,4-tetrahydroquinoline derivatives and their use as bromodomain inhibitors

#921
20160009717
2016-01-14

Substituted-quinoxaline-type bridged-piperidine compounds as ORL-1 modulators

#922
20160009710
2016-01-14

Substituted triazolopyridines and methods of use thereof

#923
20160009659
2016-01-14

Pyrimidine carboxamides as sodium channel blockers

#924
20160002236
2016-01-07

Sodium salt of (2S, 5R)-6-benzyloxy-7-oxo-1,6-diaza-bicyclo [3.2.1] octane-2-carboxylic acid and its preparation

#925
20160002235
2016-01-07

Process for preparation of (2S, 5R)-7-oxo-6-sulphooxy-2[((3R)-piperidine-3-carbonyl)-hydrazino carbonyl]-1,6-diaza-bicyclo [3.2.1]-octane

#926
20160002234
2016-01-07

Process for preparation of (2S, 5R)-7-oxo-6-sulphooxy-2-[((3R)-pyrrolidine-3-carbonyl)-hydrazino carbonyl]-1,6-diaza-bicyclo[3.2.1]octance

#927
20160002233
2016-01-07

(2S, 5R)-sulfuric acid mono-{[(4-aminopiperidin-4-yl) carbonyl]-7-oxo-1,6-diaza-bicyclo[3.2.1]-oct-6-yl} ester

#928
20150361060
2015-12-17

CENTRALLY ACTIVE AND ORALLY BIOAVAILABLE ANTIDOTES FOR ORGANOPHOSPHATE EXPOSURE AND METHODS FOR MAKING AND USING THEM

#929
20150353529
2015-12-10

Antiviral compounds

#930
20150344488
2015-12-03

Solid forms of an antiviral compound

#931
20150336957
2015-11-26

Nitrogen containing heterocyclic compounds

#932
20150336893
2015-11-26

1-[m-carboxamido(hetero)aryl-methyl]-heterocyclyl-carboxamide derivatives

#933
20150328201
2015-11-19

Nitrogen containing compounds

#934
20150322067
2015-11-12

Nitrogen containing compounds and their use

#935
20150322066
2015-11-12

Substituted benzimidazole-type piperidine compounds and uses thereof

#936
20150315209
2015-11-05

Heterocyclic compounds having cholesterol 24-hydroxylase activity

#937
20150315201
2015-11-05

Indole and indoline-type piperidine compounds and uses thereof

#938
20150315159
2015-11-05

Azepane derivatives and methods of treating hepatitis B infections

#939
20150307515
2015-10-29

Compositions and methods for inhibition of the JAK pathway

#940
20150307509
2015-10-29

Fused ring compounds as hepatitis C virus inhibitors, pharmaceutical compositions and uses thereof

#941
20150299198
2015-10-22

Inhibitors of the renal outer medullary potassium channel

#942
20150291647
2015-10-15

Compositions and methods for 18F-fluorodeoxyglycosylamines

#943
20150284408
2015-10-08

Inhibitors of DNA gyrase for the treatment of bacterial infections

#944
20150284389
2015-10-08

N-substituted indazole sulfonamide compounds with selective activity in voltage-gated sodium channels

#945
20150284378
2015-10-08

Isothiazole derivatives as PIM kinase inhibitors and preparation methods and use in medicinal manufacture thereof

#946
20150284373
2015-10-08

Pyrimidine derivatives as PIM kinase inhibitors and preparation methods and use in medicinal manufacture thereof

#947
20150284363
2015-10-08

Pyridine derivatives as PIM kinase inhibitors and preparation methods and use in medicinal manufacture thereof

#948
20150284331
2015-10-08

Fluorine substituted cyclic amine compounds and preparation methods, pharmaceutical compositions, and uses thereof

#949
20150274725
2015-10-01

Tropomyosin-related kinase (TRK) inhibitors

#950
20150274638
2015-10-01

Complex and structurally diverse compounds

#951
20150259344
2015-09-17

IMIDAZOLE DERIVATIVE

#952
20150252050
2015-09-10

Substituted glycinamides, process for their manufacture and use thereof as medicaments

#953
20150246920
2015-09-03

Crystalline forms of trans-7-oxo-6-(sulphooxy)-1,6-diazabicyclo[3,2,1]octane-2-carboxamide sodium salt

#954
20150239840
2015-08-27

Compounds useful for producing an optically active diazabicyclooctane compound

#955
20150239832
2015-08-27

ANALOGS AND PRODRUGS OF LOOP DIURETICS, INCLUDING BUMETANIDE, FUROSEMIDE AND PIRETANIDE; COMPOSITIONS AND METHODS OF USE

#956
20150232444
2015-08-20

Therapeutics targeting truncated adenomatous polyposis coli (APC) proteins

#957
20150225410
2015-08-13

Heterocyclic compounds and uses thereof

#958
20150224113
2015-08-13

6-(5-hydroxy-1H-pyrazol-1-yl)nicotinamide inhibitors of PHD

#959
20150218154
2015-08-06

Phosphatidylinositol 3-kinase inhibitors

#960
20150210681
2015-07-30

GLUCOSYLCERAMIDE SYNTHASE INHIBITORS

#961
20150210652
2015-07-30

Substituted triazines for malaria treatment and chemoprophylaxis

#962
20150210647
2015-07-30

ATX modulating agents

#963
20150203515
2015-07-23

Compounds that are S1P modulating agents and/or ATX modulating agents

#964
20150203494
2015-07-23

Pyridonemorphinan analogs and biological activity on opioid receptors

#965
20150203493
2015-07-23

Compounds that are S1P modulating agents and/or ATX modulating agents

#966
20150203492
2015-07-23

Dihydropyridone p1 as factor XIa inhibitors

#967
20150196550
2015-07-16

Peripherally acting opioid compounds

#968
20150191482
2015-07-09

Substituted imidazo[1,2-a]pyrazines as TNF activity modulators

#969
20150191466
2015-07-09

Tropomyosin-related kinase (Trk) inhibitors

#970
20150183787
2015-07-02

Propellane-based compounds and the use thereof

#971
20150183786
2015-07-02

Bicyclic aza-amides for treatment of psychiatric disorders

#972
20150175571
2015-06-25

Substituted morphinans and the use thereof

#973
20150174133
2015-06-25

Nitrogen containing compounds

#974
20150174129
2015-06-25

Substituted 2-azabicycles and their use as orexin receptor modulators

#975
20150166550
2015-06-18

Dihydropyridone P1 as factor XIa inhibitors

#976
20150166537
2015-06-18

Nitrogen containing compounds and their use

#977
20150166513
2015-06-18

Heterocyclyl pyrimidine analogues as TYK2 inhibitors

#978
20150158884
2015-06-11

Histone deacetylase inhibitors

#979
20150158864
2015-06-11

Pyrrolo[2,3-d]pyrimidinyl, pyrrolo[2,3-b]pyrazinyl and pyrrolo[2,3-d]pyridinyl acrylamides

#980
20150150866
2015-06-04

Peripheral opioid receptor antagonists and uses thereof

#981
20150141659
2015-05-21

Solid forms of an antiviral compound

#982
20150141650
2015-05-21

Derivatives of aza adamantane and uses thereof

#983
20150141643
2015-05-21

Substituted-quinoxaline-type piperidine compounds and the uses thereof

#984
20150141401
2015-05-21

Beta-lactamase inhibitor and process for preparing the same

#985
20150141394
2015-05-21

Nitrogen containing compounds and their use

#986
20150132258
2015-05-14

Azepane derivatives and methods of treating hepatitis B infections

#987
20150112070
2015-04-23

Processes for preparing heterocyclic compounds including trans-7-oxo-6-(sulphooxy)-1,6-diazabicyclo[3,2,1]octane-2-carboxamide and salts thereof

#988
20150111874
2015-04-23

Heterocyclic compounds and uses thereof

#989
20150111864
2015-04-23

CRYSTALLINE FORM OF A BETA-LACTAMASE INHIBITOR

#990
20150099781
2015-04-09

Compounds and methods for treating mammalian gastrointestinal microbial infections

#991
20150099737
2015-04-09

Pyrrolopyrimidine compounds as inhibitors of CDK4/6

#992
20150094472
2015-04-02

B-lactamase inhibitor picoline salt

#993
20150087670
2015-03-26

Compositions and methods for the treatment of respiratory disorders

#994
20150087650
2015-03-26

1-aza-bicyclo[3.3.1]nonanes

#995
20150087626
2015-03-26

Cyclic amine derivatives as EPreceptor antagonists

#996
20150080576
2015-03-19

SUB-TYPE SELECTIVE AMIDES OF DIAZABICYCLOALKANES

#997
20150080573
2015-03-19

Sulfamoylating reagents

#998
20150079028
2015-03-19

Bridged ring compounds as hepatitis C virus (HCV) inhibitors and pharmaceutical applications thereof

#999
20150073011
2015-03-12

Beta-lactamase inhibitor compounds

#1000
20150065498
2015-03-05

N-linked lactam M1 receptor positive allosteric mogulators

#1001
20150057262
2015-02-26

Cyclic P1 linkers as factor XIa inhibitors

#1002
20150051243
2015-02-19

8-azabicyclo[3.2.1]octyl-2-hydroxybenzamide compounds as mu opioid receptor antagonists

#1003
20150038482
2015-02-05

ISOXAZOLE BETA-LACTAMASE INHIBITORS

#1004
20150031675
2015-01-29

DIAZABICYCLO[3.3.1]NONANES, METHODS OF SYNTHESIS, AND USES THEREOF

#1005
20150031666
2015-01-29

1,2,4-OXADIAZOLE AND 1,2,4-THIADIAZOLE BETA-LACTAMASE INHIBITORS

#1006
20150031665
2015-01-29

1,3,4-OXADIAZOLE AND 1,3,4-THIADIAZOLE BETA-LACTAMASE INHIBITORS

#1007
20150031660
2015-01-29

1,2,4-OXADIAZOLE AND 1,2,4-THIADIAZOLE BETA-LACTAMASE INHIBITORS

#1008
20150018312
2015-01-15

Nitrogen containing compounds and their use

#1009
20150005285
2015-01-01

Nitrogen containing compounds

#1010
20140371196
2014-12-18

Diamino heterocyclic carboxamide compound

#1011
20140349995
2014-11-27

Tetrahydropyrido-pyridine and tetrahydropyrido-pyrimidine compounds and use thereof as C5A receptor modulators

#1012
20140349967
2014-11-27

Crystalline forms of trans-7-oxo-6-(sulphooxy)-1,6-Diazabicyclo[3,2,1]octane-2-carboxamide sodium salt

#1013
20140343032
2014-11-20

6-bridged heteroaryldihydropyrimidines for the treatment and prophylaxis of hepatitis B virus infection

#1014
20140329846
2014-11-06

Morphinan compounds

#1015
20140329799
2014-11-06

Aminopyrimidinones as interleukin receptor-associated kinase inhibitors

#1016
20140328805
2014-11-06

Biheteroaryl compounds and uses thereof

#1017
20140323458
2014-10-30

Substituted aliphanes, cyclophanes, heteraphanes, heterophanes, hetero-heteraphanes and metallocenes useful for treating HCV infections

#1018
20140316133
2014-10-23

Beta-lactamase inhibitors

#1019
20140315905
2014-10-23

N-adamantyl benzamides as inhibitors of 11-β-hydroxysteroid dehydrogenase

#1020
20140315880
2014-10-23

3,6-DIAZABICYCLO[3.1.1]HEPTAINES AS NEURONAL NICOTINIC ACETYCHOLINE RECEPTOR LIGANDS

#1021
20140315876
2014-10-23

BETA-LACTAMASE INHIBITORS

#1022
20140309264
2014-10-16

Acylamino-substituted fused cyclopentanecarboxylic acid derivatives and their use as pharmaceuticals

#1023
20140309213
2014-10-16

Inhibitors of the Renal Outer Medullary Potassium channel

#1024
20140309187
2014-10-16

Solid forms of an antiviral compound

#1025
20140303375
2014-10-09

Process for preparing a compound useful for producing an optically active diazabicyclooctane compound

#1026
20140303204
2014-10-09

MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR

#1027
20140303193
2014-10-09

Heteroaryl compounds useful as inhibitors of E1 activating enzymes

#1028
20140303144
2014-10-09

COMPOUNDS AND METHODS OF TREATING HYPERTENSION

#1029
20140296526
2014-10-02

Nitrogen containing compounds and their use

#1030
20140296209
2014-10-02

Compounds and methods for treatment of hypertension

#1031
20140296200
2014-10-02

6-(5-hydroxy-1H-pyrazol-1-yl)nicotinamide inhibitors of PHD

#1032
20140288064
2014-09-25

Nitrogen containing heterocyclic compounds

#1033
20140288051
2014-09-25

Bicyclic compounds and their use as antibacterial agents and beta-lactamase inhibitors

#1034
20140275549
2014-09-18

Method for producing phenyl-substituted heterocyclic derivative

#1035
20140275118
2014-09-18

Substituted 2-azabicycles and their use as orexin receptor modulators

#1036
20140275056
2014-09-18

5,6,7,8,9,10-hexahydro-6,10-epimino[1,2,4]triazolo[4,3-a]azocines as P2X7 modulators

#1037
20140275025
2014-09-18

Substituted 2-Aza-bicyclo[2.2.1]heptane-3-carboxylic acid (benzyl-cyano-methyl)-amides inhibitors of Cathepsin C

#1038
20140275020
2014-09-18

Inhibitors of the Renal Outer Medullary Potassium channel

#1039
20140275018
2014-09-18

Nitrogen containing compounds

#1040
20140275009
2014-09-18

Compounds useful as inhibitors of ATR kinase

#1041
20140275006
2014-09-18

Azole derivative

#1042
20140275001
2014-09-18

Crystalline form of a β-lactamase inhibitor

#1043
20140256940
2014-09-11

1-aza-bicyclo[3.3.1] non-4-yl)-[5-(1H-indol-5-yl)-heteroaryl]-amines as cholinergic ligands of the n-AChR for the treatment of psychotic and neurodegenerative disorders

#1044
20140249157
2014-09-04

Compounds useful as inhibitors of ATR kinase

#1045
20140249074
2014-09-04

Antiviral compounds

#1046
20140243290
2014-08-28

Aminopyrimidines as SYK Inhibitors

#1047
20140235864
2014-08-21

Biphenyl derivatives

#1048
20140235628
2014-08-21

Inhibitors of the renal outer medullary potassium channel

#1049
20140228353
2014-08-14

Methods of treating diabetes

#1050
20140221352
2014-08-07

Compositions and methods for inhibition of the JAK pathway

#1051
20140221341
2014-08-07

Bicyclic compounds and their use as antibacterial agents and betalactamase inhibitors

#1052
20140213570
2014-07-31

1,4-disubstituted pyridazine analogs there of and methods for treating SMN-deficiency-related conditions

#1053
20140206862
2014-07-24

Antioxidant small molecules aimed at targeting metal-based oxidative stress in neurogenerative disorders

#1054
20140203215
2014-07-24

Materials for organic electroluminescence devices

#1055
20140199368
2014-07-17

INTRAESOPHAGEAL ADMINISTRATION OF TARGETED NITROXIDE AGENTS FOR PROTECTION AGAINST IONIZING IRRADIATION-INDUCED ESOPHAGITIS

#1056
20140187573
2014-07-03

Substituted morphinans and the use thereof

#1057
20140187571
2014-07-03

7,8-cyclicmorphinan analogs

#1058
20140187544
2014-07-03

Oxime-substituted-quinoxaline-type piperidine compounds as ORL-1 modulators

#1059
20140187535
2014-07-03

Substituted benzimidazole-type piperidine compounds and uses thereof

#1060
20140187531
2014-07-03

Apoptosis promoters

#1061
20140179680
2014-06-26

Substituted imidazopyridines as HDM2 inhibitors

#1062
20140179673
2014-06-26

Phosphatidylinositol 3-kinase inhibitors

#1063
20140179672
2014-06-26

Amino-substituted imidazo[1,2-a]pyridinecarboxamides and their use

#1064
20140171461
2014-06-19

Nitrogen containing morphinan derivatives and the use thereof

#1065
20140163230
2014-06-12

Processes for preparing heterocyclic compounds including trans-7-oxo-6-(sulphooxy)-1,6-diazabicyclo[3,2,1]octane-2-carboxamide and salts thereof

#1066
20140163000
2014-06-12

Compounds useful as inhibitors of ATR kinase

#1067
20140162999
2014-06-12

PIM kinase inhibitors and preparation methods and use in medicinal manufacture thereof

#1068
20140162998
2014-06-12

PIM kinase inhibitors and preparation methods and use in medicinal manufacture thereof

#1069
20140161801
2014-06-12

Quinazoline derivative as tyrosine-kinase inhibitor, preparation method therefor and application thereof

#1070
20140148431
2014-05-29

1,6-diazabicyclo [3,2,1] octan-7-one derivatives and their use in the treatment of bacterial infections

#1071
20140142114
2014-05-22

Anthelmintic compounds and compositions and method of using thereof

#1072
20140113925
2014-04-24

Morphinan compounds

#1073
20140113908
2014-04-24

[(1H-INDOL-5-YL) - HETEROARYLOXY] - (1-AZA-BICYCLO [3.3.1] NONANES AS CHOLINERGIC LIGANDS OF THE N-ACHR FOR THE TREATMENT OF PSYCHOTIC AND NEURODEGENRATIVE DISORDERS

#1074
20140113890
2014-04-24

4-amino-4-oxobutanoyl peptides as inhibitors of viral replication

#1075
20140107328
2014-04-17

Chemoselective enrichment for compound isolation

#1076
20140107095
2014-04-17

Estrogen receptor modulators and uses thereof

#1077
20140088097
2014-03-27

Substituted pyrazines and their use in the treatment of disease

#1078
20140088070
2014-03-27

Nitrogen containing compounds and their use

#1079
20140088068
2014-03-27

1,6-diazabicyclo [3,2,1] octan-7-one derivatives and their use in the treatment of bacterial infections

#1080
20140080861
2014-03-20

Heterocyclic compounds with affinity to muscarinic receptors

#1081
20140080854
2014-03-20

Peripheral opioid receptor antagonists and uses thereof

#1082
20140073633
2014-03-13

Inhibitors of the shiga toxins trafficking through the retrograde pathway

#1083
20140051672
2014-02-20

1,4-disubstituted pyridazine analogs there of and methods for treating SMN-deficiency-related conditions

#1084
20140046067
2014-02-13

Alicyclic derivatives of N,N'-substituted 3,7-diazabicyclo[3.3.1]nonanes and medicaments based thereon

#1085
20140045830
2014-02-13

Cyclic urea- or lactam-substituted quinoxaline-type piperidines as ORL-1 modulators

#1086
20140045816
2014-02-13

Cyclopropyl Fused Indolobenzazepine HCV NS5B Inhibitors

#1087
20140038969
2014-02-06

DIHYDROPYRIDONE P1 AS FACTOR XIA INHIBITORS

#1088
20140031330
2014-01-30

Aryl sultam derivatives as RORc modulators

#1089
20140030190
2014-01-30

Labelled and un-labelled methyl-pyrrolyl-oxadiazolyl-diazabicyclononane derivatives and their medical use

#1090
20140024643
2014-01-23

Bridged heterocyclic compounds and methods of use

#1091
20140018317
2014-01-16

Targeted nitroxide agents

#1092
20140018313
2014-01-16

Antiviral compounds

#1093
20140011988
2014-01-09

Dibenzo[b,f][1,4]oxazepin-11-yl-N-hydroxybenzamides as HDAC inhibitors

#1094
20140011770
2014-01-09

Compositions and methods for inhibition of the JAK pathway

#1095
20140005215
2014-01-02

Selective opioid compounds

#1096
20130345190
2013-12-26

Isoxazole beta-lactamase inhibitors

#1097
20130324512
2013-12-05

Super-oxide dismutase mimetics

#1098
20130324496
2013-12-05

Solid forms of an antiviral compound

#1099
20130317054
2013-11-28

NEURONAL NICOTINIC AGONIST AND METHODS OF USE

#1100
20130317003
2013-11-28

Histone deacetylase inhibitors

#1101
20130316981
2013-11-28

Tertiary amines, medicaments containing said amines, use thereof and processes for the preparation thereof

#1102
20130310364
2013-11-21

Compositions and methods for inhibition of the JAK pathway

#1103
20130303517
2013-11-14

Quinoxalines and AZA-quinoxalines as CRTHreceptor modulators

#1104
20130303504
2013-11-14

1,3,4-oxadiazole and 1,3,4-thiadiazole β-lactamase inhibitors

#1105
20130296564
2013-11-07

Synthesis of [2.2.2]-diazabicyclic ring systems

#1106
20130296555
2013-11-07

Beta-lactamase inhibitors

#1107
20130296293
2013-11-07

1,3,4-oxadiazole and 1,3,4-thiadiazole β-lactamase inhibitors

#1108
20130296292
2013-11-07

1,3,4-oxadiazole and 1,3,4-thiadiazole β-lactamase inhibitors

#1109
20130296291
2013-11-07

1,3,4-oxadiazole and 1,3,4-thiadiazole beta-lactamase inhibitors

#1110
20130296290
2013-11-07

1,3,4-oxadiazole and 1,3,4-thiadiazole beta-lactamase inhibitors

#1111
20130289044
2013-10-31

Quinazoline compounds as sodium channel blockers

#1112
20130289020
2013-10-31

CXCR4 receptor antagonists

#1113
20130289012
2013-10-31

1,2,4-oxadiazole and 1,2,4-thiadiazole β-lactamase inhibitors

#1114
20130281483
2013-10-24

Peripheral opioid receptor antagonists and uses thereof

#1115
20130281359
2013-10-24

Bicyclic compounds and their use as antibacterial agents and β-lactamase inhibitors

#1116
20130274475
2013-10-17

BETA-LACTAMASE INHIBITORS

#1117
20130274474
2013-10-17

1,3-Oxathiolane derivatives, process for the preparation of 1,3-Oxathiolane derivatives and intermediates thereof

#1118
20130267710
2013-10-10

(1R,4R) 7-OXO-2-AZABICYCLO[2.2.2]OCT-5-ENE AND DERIVATIVES THEREOF

#1119
20130267480
2013-10-10

Crystalline forms of trans-7-oxo-6-(sulphooxy)-1,6-diazabicyclo[3,2,1]octane-2-carboxamide sodium salt

#1120
20130253186
2013-09-26

Heteroaryloxyheterocyclyl compounds as PDE10 inhibitors

#1121
20130225561
2013-08-29

Inhibitors of the renal outer medullary potassium channel

#1122
20130225554
2013-08-29

Bicyclic compounds and their use as antibacterial agents and β-lactamase inhibitors

#1123
20130217680
2013-08-22

Inhibitors of the renal outer medullary potassium channel

#1124
20130217672
2013-08-22

(+)-3-HYDROXYMORPHINAN-BASED POLYCYCLE DERIVATIVES

#1125
20130210814
2013-08-15

Cycloalkyl substituted pyrimidinediamine compounds and their uses

#1126
20130190351
2013-07-25

Bicyclic amides for enhancing glutamatergic synaptic responses

#1127
20130190308
2013-07-25

Pyrido[3,4-B]indoles and methods of use

#1128
20130190303
2013-07-25

Bridged heterocyclic compounds and methods of use

#1129
20130190293
2013-07-25

Pyrido [4,3-b] indole and pyrido [3,4-b] indole derivatives and methods of use

#1130
20130190288
2013-07-25

Benzyl sulfonamide derivatives as RORc modulators

#1131
20130184297
2013-07-18

Quinazoline derivatives substituted by aniline, preparation method and use thereof

#1132
20130184269
2013-07-18

Bridged heterocyclic compounds and methods of use

#1133
20130184253
2013-07-18

Tetrahydropyrido-pyridine and tetrahydropyrido-pyrimidine compounds and use thereof as C5a receptor modulators

#1134
20130178457
2013-07-11

Cannabinoid receptor modulators

#1135
20130172366
2013-07-04

Bridged heterocyclic compounds and methods of use

#1136
20130172327
2013-07-04

Substituted N- [1-cyano-2- (phenyl) ethyl] -2-azabicyclo [2.2.1] heptane-3-carboxamide inhibitors of cathepsin C

#1137
20130150342
2013-06-13

Pyrrolopyrimidine compounds as inhibitors of CDK4/6

#1138
20130102583
2013-04-25

Cephem compound having catechol group

#1139
20130101630
2013-04-25

HIGHLY PURE VARENICLINE OR A PHARMACEUTICALLY ACCEPTABLE SALT THEREOF SUBSTANTIALLY FREE OF METHYLVARENICLINE IMPURITY

#1140
20130096132
2013-04-18

Azaadamantane derivatives and methods of use

#1141
20130085128
2013-04-04

6-(4-hydroxy-phenyl)-3-alkyl-1H-pyrazolo[3,4-b]pyridine-4-carboxylic acid amide derivatives as kinase inhibitors

#1142
20130085126
2013-04-04

Pyrazole compounds

#1143
20130072682
2013-03-21

PROCESS FOR PREPARING VARENICLINE, VARENICLINE INTERMEDIATES, AND PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF

#1144
20130053379
2013-02-28

4-aryl-2-anilino-pyrimidines

#1145
20130053363
2013-02-28

Imidazo[1,2-a]pyridine derivative

#1146
20130045165
2013-02-21

4-fluoro-4-arylpiperdin-1-yl derivatives as mu opioid function moderators

#1147
20130040931
2013-02-14

Amino heteroaryl compounds as beta-secretase modulators and methods of use

#1148
20130040930
2013-02-14

Amide derivative and use thereof as medicine

#1149
20130032754
2013-02-07

Method for producing 3,7-diaza-bicyclo[3.3.1]nonane-metal complex solutions

#1150
20130030179
2013-01-31

PROCESS FOR THE PREPARATION OF VARENICLINE

#1151
20130030008
2013-01-31

Acylamino-substituted fused cyclopentanecarboxylic acid derivatives and their use as pharmaceuticals

#1152
20130023502
2013-01-24

Substituted pyridinyl-pyrimidines and their use as medicaments

#1153
20130011929
2013-01-10

Peripheral opioid receptor antagonists and uses thereof

#1154
20130005789
2013-01-03

Nicotinic acetylcholine receptor sub-type selective amides of diazabicycloalkanes

#1155
20130005755
2013-01-03

Peripherally acting opioid compounds

#1156
20130004428
2013-01-03

Diazabicyclononyl oxadiazole compounds and their use as nicotinic acetylcholine receptor modulators

#1157
20120329828
2012-12-27

Cocaine analogs and methods of preparation and uses thereof

#1158
20120323010
2012-12-20

Processes for preparing heterocyclic compounds including trans-7-oxo-6-(sulphooxy)-1,6-diazabicyclo[3,2,1]octane-2-carboxamide and salts thereof

#1159
20120323004
2012-12-20

Methods of producing sulfate salts of cations from heteroatomic compounds and dialkyl sulfates and uses thereof

#1160
20120322791
2012-12-20

Pyrazolo[1,5-a]pyrimidine compounds as mTOR inhibitors

#1161
20120321969
2012-12-20

SYNTHESIS OF HETERO COMPOUNDS USING DIALKYLCARBONATE QUATERNATION

#1162
20120321967
2012-12-20

Ionic liquid containing sulfonate ions

#1163
20120316343
2012-12-13

Reductive amination of 6-keto morphinans by catalytic hydrogen transfer

#1164
20120316191
2012-12-13

Peripheral opioid receptor antagonists and uses thereof

#1165
20120309960
2012-12-06

Macrocycles as factor XIa inhibitors

#1166
20120309737
2012-12-06

3,6-diazabicyclo[3.1.1]heptanes as neuronal nicotinic acetycholine receptor ligands

#1167
20120302538
2012-11-29

Substituted aliphanes, cyclophanes, heteraphanes, heterophanes, hetero-heteraphanes and metallocenes useful for treating HCV infections

#1168
20120289572
2012-11-15

Nicotinic acetylcholine receptor sub-type selective amides of diazabicycloalkanes

#1169
20120283249
2012-11-08

Novel compounds which have a protective activity with respect to the action of toxins and of viruses with an intracellular mode of action

#1170
20120277433
2012-11-01

PROCESS FOR THE PREPARATION OF SUBSTITUTED QUINOXALINES

#1171
20120277205
2012-11-01

Derivatives of N-[(1-pyrazol-1-yl)aryl]-1-indole or 1-indazole-3-carboxamide, preparation thereof and applications thereof in therapeutics

#1172
20120277192
2012-11-01

Aminopyrimidines as SYK inhibitors

#1173
20120276050
2012-11-01

Methods and compositions of treating a flaviviridae family viral infection

#1174
20120276001
2012-11-01

Bifunctional polyazamacrocyclic chelating agents

#1175
20120270917
2012-10-25

Adamantane analogs

#1176
20120270853
2012-10-25

Arylpropionamide, arylacrylamide, arylpropynamide, or arylmethylurea analogs as factor XIa inhibitors

#1177
20120264711
2012-10-18

Antiviral compounds

#1178
20120245195
2012-09-27

Monohydrate of azaadamantane derivatives

#1179
20120238740
2012-09-20

NON-POLAR AND POLAR LEAVING GROUPS

#1180
20120238553
2012-09-20

NOVEL BENZODIOXOLYL-OXADIAZOLYL-DIAZABICYCLONONANE DERIVATIVES AND THEIR MEDICAL USE

#1181
20120232280
2012-09-13

Derivatives of (bridged piperazinyl)-1-alkanone and use thereof as p75 inhibitors

#1182
20120220566
2012-08-30

Antimicrobial compounds and methods of making and using the same

#1183
20120208841
2012-08-16

Modulators of cystic fibrosis transmembrane conductance regulator

#1184
20120208796
2012-08-16

Heterocyclic derivatives

#1185
20120202807
2012-08-09

Azabicycloalkane derivatives, preparation thereof and use thereof in therapy

#1186
20120202783
2012-08-09

Fused heterocyclic compounds as orexin receptor modulators

#1187
20120184535
2012-07-19

Compound, a process for its preparation, a pharmaceutical composition, use of a compound, a method for modulating or regulating serine/threonine kinases and a serine/threonine kinases modulating agent

#1188
20120172353
2012-07-05

1,4-diaza-bicyclo[3.2.2]nonyl oxadiazolyl compounds and their medical use

#1189
20120165533
2012-06-28

Optically active diazabicyclooctane derivatives and process for preparing the same

#1190
20120157404
2012-06-21

Antiviral compounds

#1191
20120149677
2012-06-14

Ether benzotriazole derivatives

#1192
20120136024
2012-05-31

3-substituted-2-(arlyalkyl)-1-azabicycloalkanes and methods of use thereof

#1193
20120122834
2012-05-17

Small molecule CD4 mimetics and uses thereof

#1194
20120108575
2012-05-03

2,3,4,5-tetrahydro-benzo{B}{1,4}diazepine-comprising compounds of formula(III) for treating pain

#1195
20120101096
2012-04-26

Compounds and methods for treating mammalian gastrointestinal microbial infections

#1196
20120095217
2012-04-19

FLUORINE CONTAINING COMPOUNDS AND METHODS OF USE THEREOF

#1197
20120095039
2012-04-19

Heterocyclic compounds with affinity to muscarinic receptors

#1198
20120095010
2012-04-19

Tricyclic δ-opioid modulators

#1199
20120077801
2012-03-29

Chemical Compounds 637

#1200
20120071482
2012-03-22

Heteroaryl compounds useful as inhibitors of E1 activating enzymes